-
Are you talking to your patients about pelvic floor disorders (PFDs)? You should. Results from a study of 4,000 U.S. women ages 25-84 indicate one-third of them reported one or more pelvic floor disorders.
-
-
-
The greatest challenge for any potentially mortal disorder is to prove that therapeutic interventions reduce not only disease-specific mortality, but also all-cause mortality.
-
This single center prospective observational study finds that the utility of a routine daily chest x-ray (CXR) for an ICU patient is quite limited. A change in practice to ordering CXR only when clinically indicated did not adversely impact patient outcome but reduced CXR volume and overall costs.
-
Neither training in working techniques nor use of lifting equipment appears to prevent back pain or back-related disability.
-
Lower serum testosterone in men aged 60 and over was associated with increased fracture risk (especially hip and nonvertebral), even after adjusting for other major risk factors for fracture.
-
Wyeth Pharmaceuticals has received approval to market desvenlafaxine for the treatment of depression. The drug is the major active metabolite of venlafaxine (Effexor ). Wyeth has formulated the drug in a once-daily extended-release tablet. It will be marketed under the trade name Pristiq.
-
Disruptive behaviors are a poor prognostic sign in patients with Alzheimer's disease.
-
This article is designed to refresh and update the community emergency physician knowledge base for the assessment and management of pediatric chest trauma.